Whalesbook
Bhai, India ki pharma industry waise bhi duniya mein badi hai, teesre number par hai volume mein aur gyarahvein par value mein. Abhi apna domestic market $60 billion ke aas paas hai, lekin experts keh rahe hain ki 2030 tak ye $130 billion ko paar kar jayega! Health ki badhti hui zaruraten, exports aur naye-naye innovations isko fuel kar rahe hain. Is boom ki wajah se, investors ka dhyan pharma mutual funds par ja raha hai jo sector ki growth ko pakad sakte hain.
Toh, chalo dekhte hain kaunse top pharma mutual funds ne pichhle 3 aur 5 saal mein sabse badhiya performance dikhaya hai aur benchmark ko kaise maat di hai:
- ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund: Iska AUM ₹62.93 billion hai aur 5 saal ka CAGR 16.10% raha hai, jo iske benchmark BSE Healthcare TRI (15.08%) se thoda zyada hai. Iske top holdings mein Sun Pharmaceutical Industries Ltd. aur Cipla Ltd. jaise bade naam hain.
- SBI Healthcare Opportunities Fund: Ye fund peeche nahi hai! Isne 5 saal mein 17.55% ka CAGR diya hai, jo BSE Healthcare TRI (15.09%) se bhi aage hai. Ye fund bade aur mid-cap healthcare stocks par focus karta hai.
- UTI Healthcare Fund: Ye fund mid-cap aur small-cap companies mein invest karta hai. Haalanki 3 saal ka return (24.93%) benchmark se thoda kam raha, lekin 1 saal mein isne 8.33% dekar benchmark (6.27%) ko piche chhod diya.
- Tata India Pharma & Healthcare Fund: Iska performance thoda dheema raha hai. 3 saal mein isne 7.62% diya, jo benchmark (11.53%) se kam hai. Ye large-cap aur small-cap dono mein invest karta hai.
- DSP Healthcare Fund: Ye fund Indian aur global dono markets mein invest karta hai. Iska 5 saal ka CAGR 13.64% raha, jo benchmark (14.33%) se thoda neeche hai.
Yaad rakho, sirf headline returns dekh kar invest nahi karna chahiye. Risk kitna hai (standard deviation, Sharpe ratio) aur fund ka expense ratio bhi check karna important hai. Sector ka future toh accha lag raha hai, par individual fund ka performance stock selection aur market conditions par depend karega.